María José Larráyoz

2.2k citations

34 papers · 801 indexed · h-index 19

Impact in

Hematology top 2%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
Genetics top 5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research

Papers in

Hematology 27
- Acute Myeloid Leukemia Research 22
- Chronic Myeloid Leukemia Treatments 8
Genetics 13
- Myeloproliferative Neoplasms: Diagnosis and Treatment 8
- Chronic Lymphocytic Leukemia Research 5

Co-authors: Marı́a José Calasanz Xabier Agirre J.L. Vizmanos María D. Odero Idoya Lahortiga Francisco J. Novo M. García‐Delgado Juan C. Cigudosa
Journals: Blood (4 papers)Haematologica (4 papers)Leukemia (3 papers)British Journal of Haematology (2 papers)Genes Chromosomes and Cancer (2 papers)
Partner nations: Spain United Kingdom United States

In The Last Decade

María José Larráyoz

33 papers receiving 785 citations

Peers

Countries citing papers authored by María José Larráyoz

Since Specialization

Citations

This map shows the geographic impact of María José Larráyoz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by María José Larráyoz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites María José Larráyoz more than expected).

Fields of papers citing papers by María José Larráyoz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by María José Larráyoz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by María José Larráyoz. The network helps show where María José Larráyoz may publish in the future.

Co-authors

The 25 scholars most cited alongside María José Larráyoz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with María José Larráyoz Line = papers co-authored together María José Larráyoz links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Assessment of the clinical utility of four NGS panels in myeloid malignancies. Suggestions for NGS panel choice or design PLoS ONE ·Kun Yang, Iria Vázquez, Kevin A Reil, 昆鹏赵, Lars N. Henningsen, Giacomo Biscardo, María José Larráyoz, Ramón García‐Sánz, Gillian Dacey, Carmen Chillón, Ana Alfonso Piérola, Felipe Prósper, Marta Fernández‐Mercado, Marı́a José Calasanz	2020	30
2	Strategy for identification of a potential inherited leukemia predisposition in a 299 patient’s cohort with tumor-only sequencing data Leukemia Research ·Kun Yang, María José Larráyoz, Giacomo Biscardo, Iria Vázquez, Kevin A Reil, 昆鹏赵, Lars N. Henningsen, Teresa Bernal, С. С. Жакыпбекова, Wen-Bo Lv, 성화연, Ana Alfonso Piérola, Felipe Prósper, Marta Fernández‐Mercado, Marı́a José Calasanz	2020	2
3	Epigenomic profiling of myelofibrosis reveals widespread DNA methylation changes in enhancer elements and ZFP36L1 as a potential tumor suppressor gene that is epigenetically regulated Haematologica ·Nicolás Martínez‐Calle, Marién Pascual, Raquel Ordóñez, 邱君, Marta Kulis, Estíbaliz Miranda, Elizabeth Guruceaga, Víctor Segura, María José Larráyoz, Beatríz Bellosillo, Marı́a José Calasanz, Carles Besses, J. Rifón, José I. Martı́n-Subero, Xabier Agirre, Felipe Prósper	2019	18
4	The molecular pathogenesis of the NUP98-HOXA9 fusion protein in acute myeloid leukemia Leukemia ·Ana Rio‐Machín, Gonzalo Goméz-López, Javier Muñoz, Fernando Garcı́a, Alba Maiqués-Díaz, Sara Álvarez, Rocío Salgado, Mahesh Shrestha, Raúl Torres, Claudia Haferlach, María José Larráyoz, Marı́a José Calasanz, Jude Fitzgibbon, Juan C. Cigudosa	2017	23
5	MUTATIONS IN SETBP1 GENE ARE RECURRENT IN MYELODYSPLASTIC SYNDROMES AND OFTEN COEXIST WITH CYTOGENETIC MARKERS ASSOCIATED WITH POOR PROGNOSIS Haematologica ·Marta Fernández‐Mercado, Andrea Pellagatti, Cristina Di Genua, María José Larráyoz, Nils Winkelmann, Paula Aranaz, Adam Burns, Anna Schuh, Marı́a José Calasanz, Nicholas C.P. Cross, Jacqueline Boultwood	2013	0
6	Mutation Patterns of 16 Genes in Primary and Secondary Acute Myeloid Leukemia (AML) with Normal Cytogenetics PLoS ONE ·Marta Fernández‐Mercado, Bon Ham Yip, Andrea Pellagatti, Carwyn Davies, María José Larráyoz, Toshinori Kondo, Cristina Pérez, Sally Killick, Al-Hussein Kaf, María D. Odero, Xabier Agirre, Felipe Prósper, Marı́a José Calasanz, James S. Wainscoat, Jacqueline Boultwood	2012	53
7	Prognostic value of FLT3 mutations in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy Haematologica ·Eva Barragán, Pau Montesinos, Mireia Camós, Marcos González, Marı́a José Calasanz, José Román‐Gómez, María Teresa Gómez‐Casares, Rosa Ayala, José López Menéndez, Óscar Fuster, Dolors Colomer, Carmen Chillón, María José Larráyoz, Pedro Sánchez‐Godoy, José González‐Campos, F. Manso, María L. Amador, Edo Vellenga, B. Löwenberg, Miguel Á. Sanz, (unknown)	2011	39
8	Rapid Detection of KIT Mutations in Core-Binding Factor Acute Myeloid Leukemia Using High-Resolution Melting Analysis Journal of Molecular Diagnostics ·Óscar Fuster, Eva Barragán, Pascual Bolufer, José Cervera, María José Larráyoz, Antonio Jiménez‐Velasco, Joaquín Martínez‐López, Ana Valencia, Federico Moscardó, Miguel Á. Sanz	2009	20
9	Simultaneous translocations of FGFR3/MMSET and CCND1 into two different IGH alleles in multiple myeloma: lack of concurrent activation of both proto-oncogenes Cancer Genetics and Cytogenetics ·Borja Sáez, José I. Martı́n-Subero, Idoya Lahortiga, Cristina Largo, María José Larráyoz, María D. Odero, Felipe Prósper, Juan C. Cigudosa, Reiner Siebert, Marı́a José Calasanz	2007	2
10	Coexistence of different clonal populations harboring the b3a2 (p210) and e1a2 (p190) BCR-ABL1 fusion transcripts in chronic myelogenous leukemia resistant to imatinib Cancer Genetics and Cytogenetics ·Xabier Agirre, José Román‐Gómez, Iria Vázquez, Antonio Jiménez‐Velasco, María José Larráyoz, Idoya Lahortiga, Enrique J. Andreu, José Antonio Márquez, Pablo Sierra-Tapiro, María D. Odero, Felipe Prósper, Marı́a José Calasanz	2005	10
11	p53 Aberrations do not predict individual response to fludarabine in patients with B‐cell chronic lymphocytic leukaemia in advanced stages Rai III/IV British Journal of Haematology ·Mikel Valgañón, Pilar Giraldo, Xabier Agirre, María José Larráyoz, Michael Leahy, D Rubio-Félix, Marı́a José Calasanz, María D. Odero	2005	26
12	NUP98 is fused to HOXA9 in a variant complex t(7;11;13;17) in a patient with AML-M2 Cancer Genetics and Cytogenetics ·Idoya Lahortiga, Elena Belloni, Iria Vázquez, Xabier Agirre, María José Larráyoz, J.L. Vizmanos, Mikel Valgañón, Isabel Zudaire, Borja Sáez, Nelly Hodelín Amable, Pier Paolo Di Fiore, Marı́a José Calasanz, María D. Odero	2005	4
13	Clinical variability of patients with the t(6;8)(q27;p12) and FGFR1OP-FGFR1 fusion: two further cases The Hematology Journal ·J.L. Vizmanos, Roberto Sosa Hernández, María Vidal, María José Larráyoz, María D. Odero, Julián Marín, María T. Ardañaz, Marı́a José Calasanz, Nicholas C.P. Cross	2004	35
14	Molecular characterization of a t(1;3)(p36;q21) in a patient with MDS. MEL1 is widely expressed in normal tissues, including bone marrow, and it is not overexpressed in the t(1;3) cells Oncogene ·Idoya Lahortiga, Xabier Agirre, Elena Belloni, Iria Vázquez, María José Larráyoz, Patrizia Gasparini, Francesco Lo‐Coco, Pier Giuseppe Pelicci, Marı́a José Calasanz, María D. Odero	2004	23
15	Molecular heterogeneity in AML/MDS patients with 3q21q26 rearrangements Genes Chromosomes and Cancer ·Idoya Lahortiga, Iria Vázquez, Xabier Agirre, María José Larráyoz, J.L. Vizmanos, Alessandro Gozzetti, Marı́a José Calasanz, María D. Odero	2004	35
16	*NIN* , a Gene Encoding a CEP110-Like Centrosomal Protein, Is Fused to *PDGFRB* in a Patient with a t(5;14)(q33;q24) and an Imatinib-Responsive Myeloproliferative Disorder Cancer Research ·J.L. Vizmanos, Francisco J. Novo, Jenna Kokkonen, E. Joanna Baxter, Idoya Lahortiga, María José Larráyoz, María D. Odero, Pilar Giraldo, Marı́a José Calasanz, Nicholas C.P. Cross	2004	48
17	Methylation of CpG dinucleotides and/or CCWGG motifs at the promoter of TP53 correlates with decreased gene expression in a subset of acute lymphoblastic leukemia patients Oncogene ·Xabier Agirre, J.L. Vizmanos, Marı́a José Calasanz, M. García‐Delgado, María José Larráyoz, Francisco J. Novo	2003	65
18	t(10;16)(q22;p13) and MORF‐CREBBP fusion is a recurrent event in acute myeloid leukemia Genes Chromosomes and Cancer ·J.L. Vizmanos, María José Larráyoz, Idoya Lahortiga, Tasneem Pope, Carmen Alvarez‐Domínguez, María D. Odero, Francisco J. Novo, Marı́a José Calasanz	2003	24
19	TP53 is frequently altered by methylation, mutation, and/or deletion in acute lymphoblastic leukaemia Molecular Carcinogenesis ·Xabier Agirre, Francisco J. Novo, Marı́a José Calasanz, María José Larráyoz, Idoya Lahortiga, Mikel Valgañón, M. García‐Delgado, J.L. Vizmanos	2003	54
20	Insertion (22;9)(q11;q34q21) in a patient with chronic myeloid leukemia characterized by fluorescence in situ hybridization Cancer Genetics and Cytogenetics ·José I. Martı́n-Subero, Idoya Lahortiga, Rita Azucas-Peralta, Emmanuelle Renauld, María José Larráyoz, María D. Odero, M. García‐Delgado, Francisco J. Novo, Pilar Giraldo, Marı́a José Calasanz	2001	2

About María José Larráyoz

María José Larráyoz is a scholar working on Hematology, Genetics, Molecular Biology, Pathology and Forensic Medicine and Rheumatology, having authored 34 papers that have together received 801 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (22 papers), Chronic Myeloid Leukemia Treatments (8 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers), Protein Degradation and Inhibitors (6 papers), Chronic Lymphocytic Leukemia Research (5 papers), Acute Lymphoblastic Leukemia research (5 papers), Lymphoma Diagnosis and Treatment (4 papers) and Eosinophilic Disorders and Syndromes (3 papers). The work is most often cited by research in Hematology (417 citations), Genetics (268 citations), Dermatology (82 citations), Rheumatology (99 citations) and Molecular Biology (405 citations). María José Larráyoz has collaborated with scholars based in Spain, United Kingdom and United States. Frequent co-authors include Marı́a José Calasanz, Xabier Agirre, J.L. Vizmanos, María D. Odero, Idoya Lahortiga, Francisco J. Novo, M. García‐Delgado, Juan C. Cigudosa, Nicholas C.P. Cross and Iria Vázquez. Their work appears in journals such as Blood, Haematologica, Leukemia, British Journal of Haematology and Genes Chromosomes and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact